ÅëÇÕ°Ë»ö
ä¿ëÁ¤º¸
ÇìµåÇåÆÃ
ÀÎÀçÁ¤º¸
Ä¿¹Â´ÏƼ
Àαâ°Ë»ö¾î
:
¿µ¾÷
¸¶ÄÉÆÃ
ÀÓ»ó
¿¬±¸
Ç°Áú°ü¸®
ÀλçÃѹ«
»ý»êÁ÷
¾à»ç
ÀÎÇã°¡
°£È£»ç
- À̹ÌÁöºä -
(400x300)
³ª¿ìÆÊ 2015.6.22ÀÏÀÚ Àüü ä¿ëÁ¤º¸
http://www.nowpharm.co.kr
ȸ»ç¸í
³ª¿ìÆÊÄÁ¼³ÆÃ
´ëÇ¥ÀÚ
ÃÖ³«¿ì
»ç¿ø¼ö
11¸í
ÀÚº»±Ý
1¾ï¿ø
»ç¾÷³»¿ë
°í±ÞÀÎÀç¾Ë¼±
¸ðÁýÁ÷Á¾
°¢ ºÎ¼º° ä¿ë
£¾
¼ö½Ãä¿ë
±Ù¹«Áö¿ª
¼¿ï
°³²±¸
´ã´ç¾÷¹«
³ª¿ìÆÊ 2015.6.22ÀÏÀÚ Àüü ä¿ëÁ¤º¸
¸ðÁýÀοø
¡Û¡Û¡Û
¸í
±Ù¹«ÇüÅÂ
Á¤±ÔÁ÷
±Þ¿©»çÇ×
ÃßÈÄÇùÀÇ
ÀÚ°Ý¿ä°Ç
¼ºº°
¹«°ü
³ªÀÌ
¹«°ü
ÇзÂ
¹«°ü
°æ·Â
¹«°ü
»ó¼¼¸ðÁý³»¿ë
³ª¿ìÆÊ 2015.6.22ÀÏÀÚ Àüü ä¿ëÁ¤º¸
ÃֽŠ±¸ÀÎ
»óÀå »óÀ§Á¦¾à»ç »ç¾÷Á¦ÈÞ¾÷¹« (BD¾÷¹«) Á÷¿ø ¸ðÁý
(´ã´ç¾÷¹«)
±¹³» MNC BDÆÀ ³×Æ®¿öÅ·, Á¤º¸¼öÁý(½Ç¹«´ã´ç)
-»ç¾÷¼ºÆò°¡,Business Proposal ÀÛ¼º, Çù»óÁøÇà(°ü¸®)
-Á¦ÈÞ°è¾à:Co-marketing, Co-promotion, L/I, L/O(°ü¸®)
-Á¦ÈÞ°ü¸®
(ÀÚ°Ý¿ä°Ç)
Á¦¾à»ç °æ·Â 7³â ÀÌ»ó °æ·ÂÀڷμ BD¾÷¹« °æ·Â 5³â ÀÌ»óÀÚ
-¿µ¾îÈÈ °¡´ÉÀÚ
-¾àÇÐ,ÈÇÐ,»ý¸í°øÇаú Á¹¾÷ÀÌ»óÀÚ
-¾à»ç¿ì´ë
-35~45¼¼³»
»óÀå´ë±â¾÷ À§¼öŹ»ý»ê ¿µ¾÷ ´ã´ç Ãʺù
(´ã´ç¾÷¹«)
. ¿ÏÁ¦Ç° À§¼öŹ»ý»ê ¿µ¾÷
. °í°´°ü¸®,½Å±Ô°³Ã´
(ÀÚ°Ý¿ä°Ç)
. À§¼öŹ°æ·Â 5-10³â
»óÀåÁ¦¾à´ë±â¾÷ Ç°Áú°ü¸®¾à»ç ¸ðÁý
(´ã´ç¾÷¹«)
ÀǾàÇ° GMP Á¦Á¶¾÷¼Ò Ç°Áú Àü¹Ý
(ÀÚ°Ý¿ä°Ç)
¾à»ç¸éÇã Çʼö
Ç°Áú°ü¸® °æ·Â 10³â ÀÌ»ó
Áß°ßÁ¦¾à»ç ÇØ¿ÜRA °æ·Â»ç¿ø ¸ðÁý
(´ã´ç¾÷¹«)
1.ÇØ¿ÜÀǾàÇ° ÀÎ,Çã°¡ ¾÷¹«(¹Ì±¹, À¯·´ µî)
2.CTDÀÛ¼º/°ËÅä
(ÀÚ°Ý¿ä°Ç)
1. ÇØ´ç¾÷¹« 7³âÀÌ»ó °æ·ÂÀÚ
2. QA/QC°æ·ÂÀÚ,¿µ¾î ´É¼÷ÀÚ ¿ì´ë
3. ÃæºÏ ¿Àâ ±Ù¹«¤»
»óÀå´ë±â¾÷ Á¦¾àÀÚȸ»ç Ç°Áú°æ·ÂÀÚ ¸ðÁý
(´ã´ç¾÷¹«)
Ç°¸ñÇã°¡ ½ÅûÀÚ·á °ËÅä/ÀÛ¼º
Á¦Á¶ ¹× ½ÃÇè ±â·Ï °ËÅä / SOP Á¦Á¤ ¹× °³Á¤
(ÀÚ°Ý¿ä°Ç)
Á¦¾àȸ»ç QA/QC 5³âÀÌ»ó °æ·Â
»óÀå´ë±â¾÷ÀÚȸ»ç ÀÚÀç,¹°·ù ÆÀÀå ¸ðÁý
(´ã´ç¾÷¹«)
ÀǾàÇ° Á¦Á¶ ÀÚÀç¹°·ù ¾÷¹« Àü¹Ý
(ÀÚ°Ý¿ä°Ç)
1) ÀÚÀç¹°·ù °ü¸®
2) ¹°·ù/Ī·® °ü¸®¾÷¹«
3) ÀǾàÇ°Á¦Á¶ ÀÚÀç 10³âÀÌ»ó °æ·Â
4) ÃæºÏ ¿Àâ±Ù¹«
»óÀå´ë±â¾÷ Á¦¾àÀÚȸ»ç Á¦Á¶°ü¸®ÆÀÀå ¸ðÁý
(´ã´ç¾÷¹«)
¿¬±¸ °³¹ß¹®¼ °ËÅä
Á¤±â qualification °ü¸®
SOP, ±â·Ï¼ µî ¹®¼ °ü¸®
»ý»ê°èȹ ¼ö¸³
(ÀÚ°Ý¿ä°Ç)
¿µ¾î ÀÛ¹® ¹× È¸È °¡´ÉÀÚ
³»¿ë°íÇüÁ¦ Àüü°øÁ¤ À¯°æÇèÀÚ
c-GMP, EU-GMP, ICH guideline ÀÌÇØ
¾àÇÐ ¹× ÀÌ°ø°è¿ ÇÐÀ§ÃëµæÀÚ
¾à»ç ¿ì´ë
US, EU Inspection À¯°æÇèÀÚ
¿Ü±¹°è±â¾÷ RA ¾÷¹« °æ·ÂÀÚ ¸ðÁý
(´ã´ç¾÷¹«)
Prepare submissions for the new product registration (GMP, DMF, Pharmaceutical Equivalence Test etc.)
Initiate, track and facilitate new product registrations and achieve on-time approvals ( from sending POF to approval)
Ensure maintenance of registered product license (Variations, Re-evaluation, Annual report etc.)
Monitor regulatory environment changes, and provide impact analysis plus action plans to ensure compliance
Assist Regulatory Affairs Manager to establish, develop and maintain close working relationships with the relevant regulatory authorities and associations
Assists Regulatory Affairs Manager for coordinating regulatory activities between Divisions/Business Units and have timely communications with BU RA, Regional RA
Timely update and regularly check global RA database, RegTrack and Sharepoint
(ÀÚ°Ý¿ä°Ç0
Experience & Academics
Have experience in RA at least 3~5 years
University graduated / Majored in Pharmacy.
*±¹,¿µ¹® À̷¼,°æ·Â±â¼ú¼, »çÁø ÷ºÎ
»óÀåÁß°ßÁ¦¾à»ç ¼ÒȱâPM Ãʺù
(´ã´ç¾÷¹«)
. GI Product managing
. GI KOL management
(ÀÚ°Ý¿ä°Ç)
. ¼Òȱ⸶ÄÉÆà 5³âÀÌ»ì
. ¼º°ú ¿ì¼öÀÚ
»óÀåÁß°ßÁ¦¾àȸ»ç Á¦Á¶°ü¸®¾à»ç ¸ðÁý
(´ã´ç¾÷¹«)
ÀǾàÇ° GMP Á¦Á¶¼Ò Á¦Á¶°ü¸®
(ÀÚ°Ý¿ä°Ç)
ÀǾàÇ° GMP Á¦Á¶¼Ò Á¦Á¶°ü¸® °æ·ÂÀÚ ¶Ç´Â ½ÅÀÔ
¾à»ç¸éÇã Çʼö
»óÀåÁß°ßÁ¦¾à»ç Á¦Á¦¿¬±¸ Ã¥ÀÓ¿¬±¸¿ø ¸ðÁý
(´ã´ç¾÷¹«)
Á¦Á¦¿¬±¸
(ÀÚ°Ý¿ä°Ç)
°ü·Ã Àü°øÀڷμ ¼®»çÇÐÀ§ ÀÌ»ó ¼ÒÁöÀÚ
- ¾à»ç ¿ì´ë, ¹Ú»ç ¿ì´ë
- Á¦¾àȸ»ç Á¦Á¦¿¬±¸ °ü·Ã Ã¥ÀÓ¿¬±¸¿ø±Þ ÀÌ»óÀÚ ¿ì´ë
»óÀåÁß°ßÁ¦¾à»ç Ç°Áú°ü¸®¾à»ç ¸ðÁý
(´ã´ç¾÷¹«)
ÀǾàÇ° GMP Á¦Á¶¼Ò Ç°Áú°ü¸®
(ÀÚ°Ý¿ä°Ç)
ÀǾàÇ° GMP Á¦Á¶¼Ò Ç°Áú°ü¸® °æ·Â ¶Ç´Â ½ÅÀÔ
¾à»ç¸éÇãÇʼö
Àüü ±¸ÀÎ
<°³¹ß ºÎ¹®>
1 Áß°ßÁ¦¾à»ç °³¹ß Â÷Àå-ºÎÀå °³¹ß,µî·Ï¾÷¹«/,ÀÎÇã°¡/¾à»ç¸éÇã¼ÒÁöÀÚ,¸®´õ½Ê ¹× ÃßÁø·Â/½ÅÁ¦Ç° °³¹ß ´É·Â/12³â
2 Áß°ßÁ¦¾à»ç °³¹ß¾÷¹« »ç¿ø-ºÎÀå °³¹ß¾÷¹« 2³â ÀÌ»ó°æ·ÂÀÚ.¾à»ç,°³¹ß,µî·Ï,¶óÀ̼¾½Ì,BD¾÷¹«µî
3 Áß°ßÁ¦¾à»ç °³¹ßÆÀÀå °úÀå Á¶Á÷°ü¸®/½ÅÁ¦Ç° °³¹ß/Çмú//10³âÀÌ»ó/Çؿܾ÷¹«°æ·ÂÀÚ/¾à»ç/¿µ¾î
4 Áß°ßÁ¦¾à»ç °³¹ß ¸éÁ¢ÈÄ °³¹ß¾÷¹« °æ·ÂÀÚ ,¾à»ç
5 Áß°ßÁ¦¾à»ç RA,°³¹ß »ç¿ø-Â÷Àå µî·Ï¾÷¹« °æ·ÂÀÚ,½ÅÀÔÀ¸·Î µî·Ï¾÷¹« Èñ¸ÁÀÚ.¾à»ç ȯ¿µ 5³âÀÌ»ó
6 ´ë±â¾÷ °³¹ßµî·Ï(3) ÁÖÀÓ-Â÷Àå Á¦¾à»ç °³¹ßµî·Ï¾÷¹« °æ·ÂÀÚ,¾à»ç,¶óÀ̼¾½Ì¾÷¹« °æ·ÂÀÚ
7 ¿ø·áÀǾàÇ°»ç RA ´ë¸®-Â÷Àå ¿ø·áÀǾàÇ° Çã°¡µî·Ï¾÷¹« 3³â ÀÌ»ó °æ·ÂÀÚ, ¿µ¾î,¾à»ç¿ì´ë,ÆDZ³±Ù¹«,API¼±Á¤
8 ´ë±â¾÷ °³¹ßµî·Ï Â÷-ºÎÀå±Þ Á¦¾à»ç °³¹ßµî·Ï¾÷¹« 10³â ÀÌ»ó °æ·ÂÀÚ,¾à»ç,¿Ü±¹¾î ¿ì¼öÀÚ È¯¿µ,³²>¿©
9 ´ë±â¾÷ RA ÁÖÀÓ- RA¾÷¹« °æ·ÂÀÚ,ÇØ¿Ü°Å·¡¼± ¿¬¶ô,ÀÓ»óµî·Ï Áö¿ø,´ë°ü¾÷¹«µî
10 ÇÕÀÚ»ç RA ÁÖÀÓ~´ë¸® Çã°¡µî·Ï/ÇØ¿ÜÁ¦Ç°°ËÅä/3-5³â/¾à»ç/¿µ¾î
11 »óÀå Áß°ßÁ¦¾à»ç °³¹ßÇмú ÁÖÀÓ~ºÎÀå °³¹ßÇмú/Á¦³×¸¯°³¹ß/Á¦Ç°±³À°/3³â/°ü·ÃÇаú
12 »óÀå Áß°ßÁ¦¾à»ç Çã°¡µî·Ï ´ë¸®~°úÀå Çã°¡µî·Ï/´ë°ü/4³âÀÌ»ó°æ·ÂÀÚ
13 »óÀå Áß°ßÁ¦¾à»ç BD/»ç¾÷°³¹ß »ç¿ø~°úÀå BD/½Å»ç¾÷¹ß±¼/2³âÀÌ»ó/¾à»ç
14 »óÀå Áß°ßÁ¦¾à»ç ¶óÀ̼¾½ÌÀξƿô °úºÎÀå ¶óÀ̼¾½ÌÀξƿô/ÇØ¿Ü°Å·¡¼±/½Å±Ô»ç¾÷°³¹ß/9³âÀÌ»ó/¿µ¾î
15 ½Å¾à°³¹ßȸ»ç RA ÁÖÀÓ~ºÎÀå °³¹ßÇã°¡µî·Ï/IND/Á¤ºÎ±â°ü/±ÔÁ¤/2³â/¾à»ç/¿µ¾î
16 ½Å¾à°³¹ßȸ»ç IPÆÀ »ç¿ø~ºÎÀå ±¹³»¿ÜƯÇã»óÇ¥Ãâ¿ø/officeaction/ÇÑ¿µÆ¯Çã¸í¼¼¼/±¹¿µÀÚ·á/ÁöÀûÀç»ê±Ç/°æ·Â/¿µ¾î±Ç»ý¹°Çаú
17 »óÀå Áß°ßÁ¦¾à»ç °³¹ßµî·Ï ÁÖÀÓ~´ë¸® ½ÅÁ¦Ç°°³¹ß/½ÃÀåÁ¶»ç/ÀÎÇã°¡/3-6³â/¾à»ç
18 »óÀåÁ¦¾à»ç °³¹ß »ç¿ø~°úÀå pipelineŸ´ç¼º/ÀÎÇã°¡/r&dÀ§¿øȸ/ÀÓ»óÁøÇà»çÇ×/½Ä¾àû/¾à»ç
19 »óÀåÁ¦¾à»ç ÀϺ»BD¶óÀ̼¾½Ì »ç¿ø~´ë¸® ÀϺ»BD¶óÀ̼¾½Ì/°Å·¡¼±/ÀϺ»Á¦¾à½ÃÀåÁ¶»ç/2-5³â/ÀϾî/¾à»ç
20 ÀÇ·áÇмúÁ¤º¸»ç ÇмúÆÀÀå °úºÎÀå ÇмúÁ¤º¸ÄÁÅÙÃ÷±âȹ/ÀǾàÁ¤º¸¹×¼Àû°³¹ß/¾à»ç/8³â/¼®»ç¿µ¾î¿ì´ë
21 ÀǾàÇ°¿ø·á°³¹ß»ç °³¹ß °úºÎÀå ¿ø·á°³¹ß/10³âÀÌ»ó/Á¦¾à»ç¿¬±¸°³¹ß°æ·Â/¼®»çÀÌ»ó¿ì´ë
22 »óÀåÁß°ß»ç °³¹ßÀÓ¿ø ÀÓ¿ø±Þ »óÀå»ç°³¹ßÀÓ¿ø/Æ÷Æ®Æú¸®¿ÀÇõ½Å/¶óÀ̼¾½ÌÁ¦³×¸¯µµÀÔ°æ·Â/´ë±â¾÷°æ·Â/¾à»ç°³¹ßÀÓ¿øÃâ½Å
23 »óÀå »óÀ§Á¦¾à»ç »ç¾÷Á¦ÈÞ(bd) °úÂ÷Àå±Þ ±¹³»MNC BDÆÀ½Ç¹«/»ç¾÷¼ºÆò°¡Á¦¾È¼ÀÛ¼ºÇù»ó/Á¦ÈÞ°ü¸®/7³â/¿µ¾î/¾à»ç/35-45¼¼
24 »óÀå Áß°ßÁ¦¾à»ç ƯÇã ÁÖÀÓ~Â÷Àå ƯÇã°ü¸®/´ë¿Ü¾÷¹«/10³âÀÌ»ó/º¯¸®»ç¿ì´ë
<¸¶ÄÉÆà ºÎ¹®>
1 »óÀåÁ¦¾à´ë±â¾÷ OTC¸¶ÄÉÆà AM ÁÖÀÓ~´ë¸® ´ëÇüÇ°¸ñPMº¸Á¶/Á¤Ã¥ÀԾȽÇÇà/3-5³â/´Éµ¿¼º
2 »óÀå Áß°ßÁ¦¾à»ç ETC PM ´ë¸®~°úÀå Àü¹®ÀǾàÇ°¸¶ÄÉÆÃ/¸ÅÃâÁ¶Á÷¿¹»ê°ü¸®/°ñ´Ù°øºñ´¢±âÈ£Èí±â¼Òȱâ/5³â
3 »óÀåÁ¦¾à´ë±â¾÷ ÀÇ·á±â¸¶ÄÉƼ ´ë¸®~°úÀå ÀÇ·á±â¸¶ÄÉÆÃ/KOL°ü¸®/ÀÇ·á±â5³â°æ·ÂÀÌ»ó
4 »óÀåÁ¦¾à´ë±â¾÷ ´ç´¢º´¿øPM °úÀå±Þ ÀÓ»ó½ÃÇè¼öÇà/³»ºÐºñKOL°ü¸®/¸¶ÄÉÆÃÅø°³¹ß/5³â/¿µ¾î
5 »óÀåÁ¦¾à´ë±â¾÷ ´ç´¢ÀÇ¿øPM °úÀå±Þ ÀÇ¿ø½ÉÆ÷Áö¾ö±âȹ½ÇÇà/ÀÇ¿øKOL°ü¸®/5³â/ÀÇ¿ø°æ·ÂÇʼö
6 Áß°ßÁ¦¾à»ç ETC¾à»çPM ´ë¸®~ºÎÀå Àü¹®ÀǾàÇ°¸¶ÄÉÆÃ/¸ÅÃ⿹»êÁ¶Á÷°ü¸®/5³â/¾à»ç
$('employ_detail_div').update($('employ_detail_textarea').value)
Á¢¼ö±â°£
ä¿ë½Ã
Á¦Ãâ¼·ù
À̷¼
Á¢¼ö¹æ¹ý
À̸ÞÀÏ, ¿Â¶óÀÎÁ¢¼ö
À̷¼¾ç½Ä
¿Â¶óÀÎ À̷¼
´ã´çÀÚ
ÃÖ³«¿ì
¿¬¶ôó
02-555-5425
À̸ÞÀÏ
npc@nowpharm.co.kr
ȨÆäÀÌÁö
http://www.nowpharm.co.kr
ȸ»çÁÖ¼Ò
[135-090] ¼¿ï °³²±¸ »ï¼ºµ¿ 157-3
ÃÖÁ¾¼öÁ¤ÀÏ : 2015³â 06¿ù 19ÀÏ
º» Á¤º¸´Â ³ª¿ìÆÊÄÁ¼³Æÿ¡¼ Á¦°øÇÑ ÀÚ·áÀ̸ç, Æĸ¶¸ÞµðÀâ´Â(Àº) ±âÀçµÈ ³»¿ë¿¡ ´ëÇÑ ¿À·ù¿Í Áö¿¬, »ç¿ëÀÚ°¡ À̸¦ ½Å·ÚÇÏ¿© ÃëÇÑ Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â Æĸ¶¸ÞµðÀâÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.
¼±ÅÃÇϽŠÀ̷¼¿Í ÀÔ·ÂÇϽŠ³»¿ëÀÌ ÇØ´ç¾÷üÀÇ ´ã´çÀÚ¿¡°Ô À̸ÞÀÏ·Î Àü¼ÛµË´Ï´Ù.
Áö¿øÀ̷¼
À̷¼¸¦ ¼±ÅÃÇØÁÖ¼¼¿ä
´ã´çÀÚ¸í
ÃÖ³«¿ì (npc@nowpharm.co.kr)
º¸³»´Â»ç¶÷
³»¿ë
°³ÀÎÁ¤º¸Ã³¸®¹æħ
|
ȸ¿ø¾à°ü
|
°í°´Áö¿ø¼¾ÅÍ
|
Á¦ÈÞ ¹× ±¤°í¹®ÀÇ
|
´ÙÀÌ·ºÆ®°áÁ¦
¼³¸³ÀÏ : 2015³â 12¿ù 02ÀÏ l °³ÀÎÁ¤º¸Ã¥ÀÓÀÚ : À±º´È£
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£ J150002023003
»ç¾÷ÀÚµî·Ï¹øÈ£ : 285-18-01963
| Åë½ÅÆǸž÷½Å°í : Á¦ 2023-ÀÎõ-0450È£
Copyright ¨Ï
Æĸ¶¸ÞµðÀâ
Co. Ltd. All rights reserved.